HaloCare Group Ltd. – Trademark Portfolio
Entity Type: 99
HaloCare Group Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HALOCARE EMPOWERING WELLNESS. The owner is based in Carlow.
Waterfront House
Mill Lane
Carlow R93N6F5 , IE
Showing of trademarks Trademarks
Trademark Classifications
HaloCare Group Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does HaloCare Group Ltd. have?
HaloCare Group Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does HaloCare Group Ltd. file in?
HaloCare Group Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.
What are HaloCare Group Ltd.'s most well-known trademarks?
HaloCare Group Ltd.'s registered trademark portfolio includes well-known marks such as HALOCARE EMPOWERING WELLNESS. These are among 1 currently registered trademark in the portfolio.
What is HaloCare Group Ltd.'s trademark registration success rate?
HaloCare Group Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.